| Literature DB >> 25279444 |
Xiaoyun Zhou1, Shivashankar Khanapur, Anja P Huizing, Rolf Zijlma, Marianne Schepers, Rudi A J O Dierckx, Aren van Waarde, Erik F J de Vries, Philip H Elsinga.
Abstract
2-(2-Furanyl)-7-[2-[4-[4-(2-[(11)C]methoxyethoxy)phenyl]-1-piperazinyl]ethyl]7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine-5-amine [(11)C]-3 ([(11)C]Preladenant) was developed for mapping cerebral adenosine A2A receptors (A2ARs) with PET. The tracer was synthesized in high specific activity and purity. Tissue distribution was studied by PET imaging, ex vivo biodistribution (BD), and in vitro autoradiography (ARG) experiments. Regional brain uptake of [(11)C]-3 was consistent with known A2ARs distribution, with highest uptake in striatum. The results indicate that [(11)C]-3 has favorable brain kinetics and exhibits suitable characteristics as an A2AR PET tracer.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25279444 DOI: 10.1021/jm501065t
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446